Patents by Inventor Teh-Ying CHOU

Teh-Ying CHOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for evaluating the efficacy of an EGFR-TKI treatment
    Patent number: 10829822
    Abstract: The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to a subject, comprising identifying the V384D mutation in said subject. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said subject after treatment can be estimated.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: November 10, 2020
    Assignee: LIHPAO LIFE SCIENCE CORP.
    Inventors: Teh-Ying Chou, Chun-Ming Tsai
  • METHOD FOR EVALUATING THE EFFICACY OF AN EGFR-TKI TREATMENT
    Publication number: 20190010561
    Abstract: The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to a subject, comprising identifying the V384D mutation in said subject. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said subject after treatment can be estimated.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 10, 2019
    Applicant: LIHPAO LIFE SCIENCE CORP.
    Inventors: Teh-Ying CHOU, Chun-Ming TSAI
  • Method for evaluating the efficacy of an EGFR-TKI treatment
    Patent number: 10106856
    Abstract: The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to a subject, comprising identifying the V384D mutation in said subject. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said subject after treatment can be estimated.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: October 23, 2018
    Assignee: LIHPAO LIFE SCIENCE CORP.
    Inventors: Teh-Ying Chou, Chun-Ming Tsai
  • METHOD FOR EVALUATING THE EFFICACY OF AN EGFR-TKI TREATMENT
    Publication number: 20150252435
    Abstract: The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to an object, comprising identifying the V384D mutation in said object. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said object after treatment can be estimated.
    Type: Application
    Filed: March 10, 2015
    Publication date: September 10, 2015
    Applicant: LIHPAO LIFE SCIENCE CORP.
    Inventors: Teh-Ying CHOU, Chun-Ming TSAI